Annovis Bio, Inc. (ANVS)
1.93
+0.01
(+0.52%)
USD |
NYSE |
Jul 02, 16:00
1.94
+0.01
(+0.52%)
After-Hours: 20:00
Annovis Bio Market Cap : 55.08M for July 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 02, 2026 | 55.08M |
| July 01, 2026 | 54.79M |
| June 30, 2026 | 53.08M |
| June 29, 2026 | 53.08M |
| June 26, 2026 | 49.08M |
| June 25, 2026 | 47.09M |
| June 24, 2026 | 48.51M |
| June 23, 2026 | 49.65M |
| June 22, 2026 | 50.51M |
| June 18, 2026 | 49.94M |
| June 17, 2026 | 49.65M |
| June 16, 2026 | 51.08M |
| June 15, 2026 | 50.80M |
| June 12, 2026 | 50.80M |
| June 11, 2026 | 52.22M |
| June 10, 2026 | 49.08M |
| June 09, 2026 | 50.51M |
| June 08, 2026 | 51.08M |
| June 05, 2026 | 53.94M |
| June 04, 2026 | 56.79M |
| June 03, 2026 | 52.79M |
| June 02, 2026 | 53.08M |
| June 01, 2026 | 51.94M |
| May 29, 2026 | 54.79M |
| May 28, 2026 | 54.22M |
| Date | Value |
|---|---|
| May 27, 2026 | 85.51M |
| May 26, 2026 | 87.64M |
| May 22, 2026 | 94.87M |
| May 21, 2026 | 91.47M |
| May 20, 2026 | 70.68M |
| May 19, 2026 | 67.22M |
| May 18, 2026 | 71.03M |
| May 15, 2026 | 71.37M |
| May 14, 2026 | 73.80M |
| May 13, 2026 | 76.92M |
| May 12, 2026 | 78.99M |
| May 11, 2026 | 67.77M |
| May 08, 2026 | 64.65M |
| May 07, 2026 | 64.08M |
| May 06, 2026 | 68.05M |
| May 05, 2026 | 64.37M |
| May 04, 2026 | 64.65M |
| May 01, 2026 | 56.71M |
| April 30, 2026 | 55.86M |
| April 29, 2026 | 52.17M |
| April 28, 2026 | 52.46M |
| April 27, 2026 | 53.59M |
| April 24, 2026 | 49.34M |
| April 23, 2026 | 51.32M |
| April 22, 2026 | 52.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 3.227B |
| Gain Therapeutics, Inc. | 81.15M |
| ACADIA Pharmaceuticals, Inc. | 4.443B |
| Alnylam Pharmaceuticals, Inc. | 41.74B |
| Anika Therapeutics, Inc. | 205.16M |
Market Cap Related Metrics
| Price to Book Value | 17.62 |
| Price | 1.93 |
| Earnings Yield | -88.95% |